Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

• Main Authors: Spencer, Andrew, Samoilova, Olga, Chng, Wee-Joo, Labotka, Richard, Li, Cong, Wu, Kwang-Wei, Saxena, Nakul, Yan, Xu, Lee, Jae Hoon, Beksac, Meral
• 其他作者: CANCER SCIENCE INSTITUTE OF SINGAPORE
• 格式: Article
• 出版: Wiley 2023
• 主題: emerging‐markets; ixazomib; multiple myeloma; overall survival; proteasome inhibitor
• 在線閱讀: https://scholarbank.nus.edu.sg/handle/10635/237497

10.1002/jha2.548